NASDAQ · DAIO
Data I/O Corporation
$2.50+$0.08 (+3.31%)
Data I/O Corporation’s quoted price sits in the lower half of its reported 52-week range, 44.32% below the high.
Loading market information…
OTC · PUMD · USD
Stock price
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
ProUroCare Medical Inc.’s quoted price sits in the lower half of its reported 52-week range, 98.02% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE COMPANY BEHIND THE TICKER
ProUroCare Medical Inc. is dedicated to developing advanced products for the accurate identification and detailed assessment of male prostate diseases. The company's primary offering is the ProUroScan System, an innovative prostate imaging solution. This system empowers physicians to precisely document prostate irregularities that have been initially discovered through a digital rectal examination. ProUroCare has entered into strategic agreements with Artann Laboratories Inc., covering the licensing, ongoing development, and market commercialization of its ProUroScan System. The company was established in 1999 and is headquartered in Eden Prairie, Minnesota.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$2.50+$0.08 (+3.31%)
Data I/O Corporation’s quoted price sits in the lower half of its reported 52-week range, 44.32% below the high.
$0.02$0.00 (0.0%)
AllDigital Holdings, Inc.’s quoted price sits in the upper half of its reported 52-week range, 11.62% below the high.
$0.00$0.00 (0.0%)
Cyberfort Software, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Innovacom Inc.’s quoted price sits in the lower half of its reported 52-week range, 40.0% below the high.
$0.00$0.00 (0.0%)
Metalert, Inc.’s quoted price sits in the lower half of its reported 52-week range, 94.12% below the high.
$0.00$0.00 (0.0%)
China Mulans Nano Technology Corp., Ltd.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Exeo Entertainment, Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.00$0.00 (0.0%)
Anvia Holdings Corporation’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
